DISCRIMINATIVE VALIDITY OF THE EQ-5D-5L AND SF-12 IN OLDER ADULTS WITH ARTHRITIS

Author(s)

Tawiah A1, Al Sayah F1, Ohinmaa A2, Johnson JA2
1University of Alberta, Edmonton, AB, Canada, 2School of Public Health, University of Alberta, Edmonton, AB, Canada

OBJECTIVES: To examine the discriminative validity of the EQ-5D-5L and the SF-12 v.2 in capturing the burden of arthritis on health-related quality of life (HRQL) of older adults.

METHODS: Cross-sectional data from the Alberta Retired Teachers Association survey were used. Known-groups approach with a-priori hypotheses was used to examine the discriminative validity of theEQ-5D-5L dimension, VAS and index scores, and SF-12 v.2 domain, summary (PCS, MCS) and index scores (SF-6D). Groups were identified based on self-reported presence of arthritis, chronic pain level, presence and number of comorbidities and self-reported health status.

RESULTS: Mean age of respondents (N=2844) was 68.6 (SD 5.9) years; 54.8% were female, with mean body mass index (BMI) of 27.2 kg/m(SD 4.8) and 36.6% reported having arthritis. The overall mean EQ-5D-5L index score was 0.86 (SD 0.11) and mean SF-6D score was 0.79 (SD 0.13). Participants with arthritis had lower EQ-5D-5L index score (0.83, SD 0.13) and SF-6D score (0.75, SD 0.13) compared to those without arthritis (0.88, SD 0.09 and 0.81, SD 0.12, respectively). EQ-5D-5L index score and SF-6D demonstrated moderate discriminative validity based on known-group analyses (effect sizes range: 0.2-0.6). Related dimensions and domains between the EQ-5D-5L and SF-12 were moderately to strongly correlated (r=0.6-0.7). Most importantly, both instruments could not adequately discriminate between patients with moderate and severe chronic pain of 6-month duration, whereby, patients with moderate chronic pain had lower index scores on both instruments compared to those with severe chronic pain.

CONCLUSIONS: Overall, the EQ-5D-5L and SF-12 v.2 demonstrated moderate discriminative validity among older adults with arthritis. However, the discriminative validity of both instruments was limited with respect to chronic pain; a very important feature of arthritis. The nature of pain (acute vs. chronic) need to be considered when choosing any of these instruments for measuring HRQL in this clinical population.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PRM173

Topic

Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×